Results 191 to 200 of about 369,580 (326)

Mechanisms of Oncogene Activation

, 2016
A. Botezatu, I. Iancu, O. Popa, A. Plesa, DanaManda, Irina Huică, S. Vladoiu, G. Anton, CorinBadiu   +8 more
semanticscholar   +1 more source

Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells

Oncogene, 2004
F. Armstrong, Marie-Michèle Duplantier, P. Trempat, C. Hieblot, L. Lamant, E. Espinos, C. Racaud-Sultan, M. Allouche, E. Campo, G. Delsol, Christian Touriol   +10 more
semanticscholar   +1 more source

Deciphering diverse cell‐death patterns to predict the prognosis and potential therapy target of hepatocellular carcinoma patients

VIEW, EarlyView.
Abstract Ninety percent of all primary liver malignancies are hepatocellular carcinomas (HCC), making liver cancer the third most common cause of cancer‐associated mortality. Different patterns of programmed cell death (PCD) are crucial for the survival of tumors, and they might serve as a prognostic marker for HCC.
Lin Ding, Qian Li, Wenjing Yang, Te Liu, Tongtong Tian, Yu Liu, Chunyan Zhang, Baishen Pan, Beili Wang, Fan Wu, Wei Guo   +10 more
wiley   +1 more source

Virus-mediated gene fusion: igniting and sustaining oncogenesis. [PDF]

Trends Cancer
Starrett GJ.
europepmc   +1 more source

The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors

Oncogene, 2002
H. Nishimori, Y. Sasaki, Koichi Yoshida, H. Irifune, H. Zembutsu, Toshihiro Tanaka, T. Aoyama, Taisuke Hosaka, S. Kawaguchi, T. Wada, J. Hata, J. Toguchida, Yusuke Nakamura, T. Tokino   +13 more
semanticscholar   +1 more source

Mass spectrometry‐based mitochondrial proteomics for cancer biomarker discovery

VIEW, EarlyView.
Figure.1 Schematic diagram of MS‐based mitochondrial proteomics for cancer biomarker discovery. The workflow highlights the integration of advanced technological platforms in mitochondrial proteomics and their application in cancer biomarker discovery.
Zheng Cao, ZiKun Song, Weijie Zhou, Xiaohui Liu, Yanling Liu, Peng R. Chen, Kun Qian   +6 more
wiley   +1 more source

Crizotinib-induced hyperlipidemia in advanced lung adenocarcinoma: A case report and literature review. [PDF]

Medicine (Baltimore)
Ren S, Chen R.
europepmc   +1 more source

Plasma Proteomics Analysis Identifying IGFBP2 as a Potential Diagnostic Biomarker for Laryngeal Squamous Cell Carcinoma

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective Currently, there are no blood biomarkers available for the early diagnosis of laryngeal squamous cell carcinoma (LSCC). The objective of this study was to search for potential plasma biomarkers for the diagnosis of LSCC. Methods Plasma samples were taken from patients with LSCC and healthy controls for proteomic analysis.
Shuang Teng, Ling‐Mei Qu, Jun‐Jie Liu, Yu‐Shan Li, Zi‐Qi Chen, Shuo Liu, Zhao‐Nan Xu, Meng Jin, Qiu‐Ying Li, Qin Wu, Hong‐Tian Yi, Xian‐Ji Shen, Bing‐Rui Yan, Ya‐Nan Sun   +13 more
wiley   +1 more source

In Silico Design and Characterization of a Rationally Engineered Cas12j2 Gene Editing System for the Treatment of HPV-Associated Cancers. [PDF]

Int J Mol Sci
Boren C, Kumar R, Gollahon L.
europepmc   +1 more source

Interaction of AF4 wild-type and AF4·MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?

Oncogene, 2004
A. Bursen, Sven Moritz, A. Gaussmann, S. Moritz, T. Dingermann, R. Marschalek   +5 more
semanticscholar   +1 more source